You searched for "testing"

3408 results found

Harnessing head and neck cancer genomics for personalised medicine

Luc Morris updates us on the future of cancer diagnosis and treatment, which lies in “personalised oncology”, where specific molecular alterations of each tumour will be identified, and matched with actionable alterations in existing therapies, ushering in the era of...

Head and neck cancer and PET-CT

Positron emission tomography-computed tomography (PET-CT) is an imaging technique in which abnormalities of tissue metabolism are precisely superimposed onto the anatomy. It relies on the premise that malignant cells are more metabolically active compared with non-malignant cells. On this basis,...

Training in Facial Plastic Surgery in the UK

Following the Keogh report earlier this year into the quality of cosmetic surgery in the UK, surgical training in cosmetic surgery is high on the agenda. A Cosmetic Surgery Interspecialty Committee at the Royal College of Surgeons is currently discussing...

Hidden hearing loss in humans: cochlear synaptopathy is superseded by cognitive effects when listening to speech in noise

Elizabeth Beach presents an overview of the recent research being undertaken at the National Acoustic Laboratories on speech in noise and its relationship to cochlear synaptopathy. Our team at the National Acoustic Laboratories (NAL) has been investigating hidden hearing loss...

Ida Institute closing down

In a significant shift for the field of hearing care, Demant has announced the closure of the Ida Institute. On 8 October, the Denmark-based hearing healthcare giant has confirmed that future developments in person-centred care will be led directly by...

Immunosuppresants and ototoxicity

There is a wide range of immunosuppressant drugs ranging from calcineurin inhibitors (e.g. cyclosporine), anti-folic agents (e.g. methotrexate) to anti-TNF and monoclonal antibodies, many of which could be ototoxic. The authors performed a systematic review assessing ototoxicity secondary to immunosuppressant...

New technology from GN Hearing addresses the No.1 hearing aid challenge: hearing speech in noise

ReSound OMNIA, the latest innovation from GN Hearing, promises to set a new standard in hearing technology.

Digital EUHA Spring Conference 2024

Save the date! The 2024 Digital EUHA Spring Conference will kick off on 22 March 2024. The online training event has an international outlook and will be available in English. For several weeks after the live conference, lectures and chats...

Hearing pioneer Gerard O'Donoghue retires

The Nottingham Auditory Implant Programme (NAIP) has announced the retirement of Professor Gerard O’Donoghue, Consultant Neuro-Otologist at Queen’s Medical Centre, Nottingham. A pioneer in the field of hearing restoration, Gerry’s career has been defined by his groundbreaking work in cochlear implantation.

Anatomy for extended sinus surgery

In the world of image guidance and pushing the boundaries of what can be achieved endoscopically the assessment and understanding of preoperative imaging is critical for success. This paper highlights the anatomical variations in the pterygopalatine and sellar regions. The...

Can we centralise cochlear implant surgery and keep most appointments close to home?

The NHS Five Year Forward View promoted seeing patients closer to home in order to provide better care, cut down on missed appointments and reduce costs. This encouraged the development of ‘hub and spoke’ models of care, but this model...

Outcomes of office-based biopsies for laryngopharyngeal carcinoma – faster diagnoses and equivalent oncological outcomes as compared to biopsies under general anaesthesia

Patients in the UK with head and neck cancers are the most likely to face long waits to treatment in comparison to other cancer sites, with only just over half commencing treatment within 62 days of being referred on a...